Cluster 1 showed higher proportions of CD19+CD27+CD24bright regulatory B cells and CD19+CD20+CD27+ bulk memory B cells, and fewer CD19+CD38brightCD27bright SLE-associated plasma cells, representing an intermediate clinical phenotype. This evidence concerns the gene CD19 and systemic lupus erythematosus.